December 29th 2023
Our top coverage from the CHEST Annual Meeting 2023 explored various topics, including strategies to prevent air pollutant exposure and keys to achieving equity in lung cancer screenings.
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Study Finds That Physicians’ Financial Conflicts of Interest May Influence Black Lung Diagnosis
March 31st 2021Researchers found that physicians may have a financial conflict of interest when examining a chest x-ray for black lung disease, suggesting that sweeping changes are needed to avoid biases and improve transparency.
Read More
Short-term Exposure to Nitrogen Dioxide May Increase Risk of Death From Respiratory Disease
March 27th 2021Exposure to nitrogen dioxide (NO2), an air pollutant generated from automobiles, may increase risk of mortality, even if the exposure amount is well below regulatory limits, investigators concluded.
Read More
Hospitalized Patients With COVID-19 May Experience Long-term Physical and Psychological Symptoms
March 17th 2021Patients discharged from hospitals after recovering from severe COVID-19 were found to have lasting functional impairment and post-traumatic stress symptoms months after, according to a study.
Read More
The FDA issues updated guidance on the emergency use authorization (EUA) process for COVID-19 screening tools; Eli Lilly releases patient-reported outcome results for Verzenio (abemaciclib) in breast cancer; COVID-19 vaccines possibly improve long-haul symptoms among patients.
Read More
Encouraging Patients With Asthma to Exercise Easier Said Than Done, Survey Finds
March 6th 2021Asthma and immunology specialists responding to a survey about physical activity for patients with asthma were mostly unaware of any guidelines but seemed willing to learn more about how to incorporate them into practice.
Read More
J&J’s COVID-19 Vaccine Moves Forward After FDA Panel Vote
February 26th 2021An FDA advisory panel Friday unanimously endorsed the third US COVID-19 vaccine, a 1-shot vaccine produced by Janssen, a subsidiary of Johnson & Johnson (J&J), and an emergency use authorization by the FDA is expected to follow shortly.
Read More
Dr Krishna Sundar: Cough Hypersensitivity Is a Key Target for Patients With Chronic Cough
February 4th 2021There needs to be a better understanding of cough drivers in patients as treatments have stopped working, said Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.
Watch
Determinants of ICS Therapy Adherence in Patients With Asthma
This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.
Read More
This Week in Managed Care: January 8, 2021
January 8th 2021This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.
Watch
Dr Megan Althoff on How, Why the GINA, ERS/ATS Guidelines Differ
December 30th 2020One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, University of Colorado.
Watch
When evaluating a patient’s response to a biologic for asthma, factors to consider include patient preference, safety, and symptoms, explained Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.
Watch
What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll
December 23rd 2020The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.
Read More